Abstract: This paper analyses the immunological response of breast cancer patients through the lens of medical semiotics. From this perspective both psychological and physiological symptoms are treated as a set of transitive signs. The symptomatic journey of breast cancer patients was documented through an ethnographic engagement with a breast cancer charity. This journey consists of diagnosis, treatment and remission, where both the physical and psychological trauma maybe irreversible. Equally the genetic disposition of each patient and the variability of the treatment give rise to a plethora of possible immunological responses. The case study organization provided both therapeutic treatment but also sold oncology products to its patients, matching the products' composition to the specific immunological responses caused by breast cancer treatment, e.g., brittle skins or hair loss, etc. This paper explores how the varied and transient nature of immunological semiosis is identified and commoditized into an economic process. This challenging social context is of interest from a semiotic stand point because it offers a singular paradigm to explain the evolution of signs and symptoms into sales.
Introduction
This paper will use a medical semiotics framework to explain the changing semiosis of breast cancer. The paper will outline the tropes within medical semiotics research while briefly covering the existing literature that connects breast cancer with semiotics. Which the reader will come to see is a heterogeneous, gendered and prevalent condition. This will be followed by extracts from ethnographic interviews with breast cancer patients. Concluding with an analysis of the usefulness of medical semiotics as framework to explain disease categories (nosology) and immunological response.
Medical semiotics
In Eugen Baer's introduction to Medical Semiotics (Baer 1988: 1) he states that the "art of healing, in Greek antiquity, was called techne semeiotike, a craft of having to do with signs." This term he describes as meaning a semiotic craft or "the skill to interpret semeia, signs " (1988: 1) . Although with the use of techne he is clearly invoking Heidegger (Heidegger 1953 (Heidegger , 1954 he progresses to Sebeok (1978: 181) to give an effective definition of Medical Semiotics as a tripod of medicine, linguistics, and philosophy. It is within this paradigm that this paper is offered, as it is posited that semiotics can provide medicine with: "A grammar of signs, refining the syntax of symptoms, disclosing their pluridimensional semantic richness, and proposing a dialogistic pragmatics of how to interact with the patient" (Baer 1988: 2) .
This grammar of signs could be related through Peirce's triadic system (Peirce i. 1839 (Peirce i. -1914 , or through Ferdinand de Saussure (1857 Saussure ( -1913 or another framework. Whichever paradigm one wishes to seat a system of medical signs in, the issues still remains that "in medicine the many ways in which we talk about symptoms constitutes our experiences of them" (Baer 1988: 5) . Hence as Kawade (1996) noted, Biology has a plethora of contradictory epistemological positions within it, and the author would hypothesis that medicine is much the same. This paper aims to highlight through empirical evidence how a specific set of symptoms is enacted between individuals and treatment schemes. It highlights the transient nature of medical signs and symptoms within a condition (Hackbarth et al. 2008) .
Existing medical semiotic literature
In the Anglophone world medical semiotics has not propagated a large body of literature in comparison to other semiotic disciplines of a more literary or typically biological nature. Medical semiotic literature covers texts that are concerned with general issues in the topic such as (Baer 1988; Brands et al. 2000; Crookshank 1923; Hess 1998; Kahn 1981; Nessa 1996; Rogers and Swadener 2001; Sebeok 1985 Sebeok , 2001a Skopek 1979; Staiano-Ross 2011; Staiano 1979; Van Den Broek 1987; Von Uexküll 1982 , others focus on the semiotics of specific medical conditions and treatments, the most prevalent being Psychiatry/Psychotherapy (Ablamowicz 1994; Aragno 2011; Craig 1997; Davtian and Chernigovskaya 2003; Donnelly 1984; Du Plessis 2012; Keinänen 2003; Kuperman and Zislin 2005; Lee and Beattie 2000; Mildenberger 2004; Peyrot 1987; Rausch 1995; Shands 1970a Shands , 1970b Stampfl 2013) . A more extensive list of these topics can be found in Tredinnick-Rowe (2016) .
Without doubt there are more publications in the medical semiotic arena that the author has omitted especially when one has to draw a line between where disciplines such as psychiatry and medicine become independent subjects. Similar arguments can be made between the boarders of biology and medicine in biosemiotics, such as the work of Favareau (2009) and his work on genetics. There will be many topics in other languages that the author does not have the skill to access. This short inchoate inventory does highlight some of the subject areas covered in medical semiotics and the dominance of literature on psychiatry or psychotherapy related topics.
The explanation of breast cancer from a semiotic perspective is covered in more depth than one might realise. For example Wagner (2005) discusses the semiotic role of breast cancer ribbons and their commercialisation. Breast cancer and identity as a literary-semiotic construct is addressed by Henriksen and Hansen (2009) , and as an auto-ethnographic experience in Sontag (1977) . Similarly DeShazer (2012) covers the semiotics of breast cancer from a photographic narrative. More photographic data on the topic was utilised by Jay (2012) in the SCAR project, and the semiotic issues around mastectomy are addressed by Cobb and Starr (2012) . Authors such as Gryder et al. (2013) have worked on a biosemiotic explanation of cancer from a genomic perspective, with reference to breast cancer. However the closet work to this paper is Crompvoets (2012) who addressed the disconnect between the marketing literature of breast prosthesis (as a result of mastectomy) and the direct experiences of the patient. To the author's knowledge this and Donnelly and Klonowski (1994) 's paper are the only other publication to have addressed the intersection of breast cancer and semiotics through a data driven, anthropological approach. Other notable papers connecting breast cancer and semiotics can be found in the 2012 Social Semiotics Journal special issue on breast cancer: Ehlers (2012); Ehlers and Krupar (2012) ; Krupar (2012); Roskelly (2012) .
Background to breast cancer
As one invariably does in medicine (and occasionally in semiotics) when a historical description of the genesis of breast cancer is required we must turn to Hippocrates "who is and remains the father and maters of all semiotics,
The semiotics of breast cancer physicians and laymen" 1 (Kleinpaul 1893: 103). Hippocrates documented short case studies of medical conditions, one of which had the following description "A woman from Abdera had a carcinoma 2 of the breast, which discharged blood, the flow was stopped, she died. 3 " (Hippocrates 1846).Which is said to be the first documented case of breast cancer (Baer 1988) . It has been suggest that by De Moulin that Hippocrates associated breast cancer with the end of menstrual cycles: "Suppression of menstrual discharge would lead to engorgement of the breast and the appearance of nodules which would become increasingly indurated and ultimately degenerate into 'hidden' cancer" (1989: 2) Where a hidden cancer is taken to mean "tumors which had not yet penetrated the skin" (De Moulin 1989: 2) . This description of cancer is clearly in the humeral tradition of Greek medicine (Hippocrates 1983) . The knowledge of the condition has evidently advanced since the Hellenic period but it is striking that Hippocrates did correctly link changes in hormonal patterns such as puberty and menopause to an increased risk of breast cancer (Bodicoat et al. 2014) . Breast Cancer as a condition is particularly gendered, only 1 % of breast cancer suffers are male (Fentiman et al. 2006 ) causing a heavy gender bias both in the service users and the service providers. Of female cancers, breast cancer accounts for 18 % of all know cases (McPherson et al. 2000) , an illustrative demography is as follows: "Of every 1,000 women aged 50, two will recently have had breast cancer diagnosed and about 15 will have had a diagnosis made before the age of 50, giving a prevalence of breast cancer of nearly 2%" (McPherson et al. 2000: 1) .
Breast Cancer has the highest incident and mortality rate of any cancer among women (WHO 2012) . The condition is propagated through the body's lymph system which is shown in Figure 1 .
The treatment of breast cancer utilizes heterogeneous schemes from radiography, chemotherapy, hormonal therapy, mastectomies, prosthesis and reconstructive surgery. This is because the tumors found in breast cancer are in fact not a singular entity ( Van't Veer et al. 2002) , but represents a spectrum of different gene expressions in the same lymph node system. That is to say the site of the tumor is in the same place in the body (the breast) but the tumors themselves that arise there do not necessarily have any commonality. As such different classes of carcinomas cause more or less severe instances of breast cancer (Li et al. 2005) . The data in regard to breast cancer was taken from an organization that produced oncology massage goods, and also runs a charity to help breast cancer suffers.
The organization
The data in this paper will be primary drawn from conversations that occurred while the researcher was on an ethnographic placement with an oncology and skin product company. Hence forth all references to this company will be given simply as the organization. The organization was set up in 1999 by an Italian medical doctor and also an herbalist who produced 100 % organic skin care (Rowley and Spiezia 2006) . The organization was based on the Lizard Peninsula in Cornwall, UK before moving into a specially designed health, well-being and innovation center within the grounds of a hospital (see Figure 2) .
The organization was the first UK Company to have Soil Association certification across its entire product range, guaranteeing their products are 100 % organic. The organization has an association with luxury as it targets The semiotics of breast cancer the ABC1 4 demographics and high-end eco-spas while also producing oncology massage oils that are used by its in-house cancer charity. Data from the organization was collected using ethnography and ethnographic interviewing, the methodology of which is detailed below.
Methodology

Ethnographic interviewing
Ethnographic interviewing is both a mix of techniques and also a process. It is largely concerned with reflexivity and the co-creation of research between 4 ABC1 refers to National Readership Survey demographic categories, crudely put ABC1 makes up a customer segment from upper class to lower-middle class. In regard to food ABC1 consumers trends are not just based on greater affluence but also on factors such as a greater awareness of health issues and ethics.
participant and researcher. Heyl defines the concept as: "those projects in which researchers have established respectful, on-going relationships with their interviewees, including enough rapport for there to be a genuine exchange of views and enough time and openness in the interviews for the interviewees to explore purposefully with the researcher the meanings they place on events in their worlds " (2001: 369) Given this working definition, Heyl (2001) went on to attempt to summarise the approach by triaging the two seminal works of Eisner and Peshkin (1990) ; Kvale and Brinkman (2009) into a four point methodology for ethnographic interviewing: 1. Listen well and respectfully, developing an ethical engagement with the participants at all stages of the project 2. Acquire a self-awareness of our role in the co-construction of meaning during the interview process; 3. Be cognisant of the ways in which both the on-going relationship and the broader social context affect the participants, the interview process, and the project outcomes; and 4. Recognize that dialogue is discovered and only partial knowledge will ever be obtained. (Heyl 2001: 370) As with ethnographic work, there is a significant amount of preparation that occurs prior to the interviews themselves. This covers not just learning the skills to analyze the interviews but also collecting data that allows the researcher to comprehend and socially place the nature of the company/patient under question. The researcher analyzed and recorded notes not just on the speech content of the interview but also the other socio-linguistic actions. The interviewees' pauses, non-verbal noises, ticks, gesticulations, contradictions and other motor and paralinguistic functions all helped to reveal information about the circumstances of the interview and the subject matter (De Vault 1990; Holstein and Gubrium 1995; Opie 1992) . In fields such as medical research and other social areas, the topics of interaction can become quite emotionally charged (Rothman 1986 ). This was an issue in regard to the researcher's ethnographic interviewing taking place with a breast cancer charity. The researcher has as a matter of reflexivity to be able to put him/herself in the place of the interviewee. Bourdieu (1993) Bourdieu talks about the role of emotion as part of an emancipatory reflexivity when he tries to comprehend the difficulties of the research participants:
The welcoming disposition, which leads one to make the respondent's problems one's own, the capacity to take that person and understand them just as they in their distinctive necessity, is a sort of intellectual love: a gaze that consents to necessity, in the manner of
The semiotics of breast cancer the 'intellectual love of God', that is, of the natural order, that Spinoza held to be the supreme form of knowledge. (Bourdieu 1993: 614) One of the other few insights into how to reflexively conduct ethnographic interviews is given by Bourdieu in The Weight of the World: "Methodical construction is 'based on a sociological 'feel' or 'eye' [that] enables one to perceive and monitor on the spot as the interview is actually being carried out, the effects of the social structure within which it is taking place" (Bourdieu 1993: 608) . This is a concept that others such as Gouldner (1971) emphasize, and leads to a well-made point by Heyl (2001: 377) : "reflexivity applies not only to the phases of active interaction during interviewing, but also to the phases of interpretation, writing and publication." It is this empathetic procedure that the researcher endeavored to employ in this study.
Data
The data will be primarily drawn from conversations that occurred with managers and therapists in the organization. The data was collected over a 3 month period in 2013, with subsequent follow-up interviews in 2014. It shows the how the symptoms associated with breast cancer are related and treated by the organization. In addition how the complications with breast cancer treatment arise in physical, psychological and legal areas is addressed. The first point to make in regard to this is that as one respondent related, the psychological trauma of breast cancer is seemingly permanent: F psychological it [breast cancer] never ever goes away … it's always there, even when you get your 5-year clearance … it's always in the back of your mind, if you get a lump or if you're coughing or if you've got headaches you're still stuck thinking 'oh my God is it coming back?'
The trauma can exacerbate routines conditions such as headaches or hypertension by acting as a psychological block about ones' health. The quote continued:
F I know people who are 10, 15 years down the line and they still feel the same … I don't know anyone who has gone back to feeling like they did before they were diagnosed … even though you get a 5-year clearance, which I have had, I still get problems and I still need sometimes the support of someone that's been through it. It's on-going. This quote illustrates how the psychological component of the disease long outlasts the physical manifestation of the condition itself (Sontag 1977) . Although there will be psychological side effects due to a physical traumas such as mastectomy (Maguire et al. 1978) , the anxieties caused by it do not typically extend themselves into other health related issues such colds, coughs etc. The interviewee also talked of the possible side effects as a result of the treatment:
F I was really lucky I didn't lose any of my finger nails or my toe nails … they can just go … [but] they are more brittle now than they use to be … so it does effect in ways you never think it is going to, like my teeth … I had 3 teeth removed since my clean report, the majority of ladies in my support group have had the same thing.
The side-effects of chemotherapy are sadly only part of the symptoms associated with breast cancer. The on-going condition and side effects are also intimately connected to the pharmaceuticals that have to be taken post-treatment (J author, P interviewee): P That's what a lot of people think is, 'Oh well, you have had your 5-year clearance, you're fine. J But it's not. P Or even when your hair grows back, you know? 'Oh, your hair's grown back, you must be better.' Actually no, you know, you can be on drugs for … I've got another 5 years on a drug yet. J Really? P Yeah. I was given my 5-year clearance and I had to be tested to say whether I was menopausal or not, and depending on what I was, I was going to be given another 5 years on the same tablet, or changed. Well, they've changed me because I was menopausal so I've been through the menopause, so they said, 'No, right,' and this other drug increases my chances even more, so … This highlights that as the condition progresses the body of the patient is also not in a static state. The interviewee entered the menopause while under treatment which altered her own internal biochemistry, leading to a change in her medical prescription. In addition to this, the pharmacology of the medication can be as complex as other parts of the treatment: P … this drug that I'm on now, that has different side effects. So the last lot of drugs I was on, I was taking 3 tablets a day, but the only one that was helping to prevent the cancer coming back was one of them called Tamoxifen. The other 2 I had to take were to counteract side effects I was getting from the Tamoxifen.
The same patient related that the immunological response is a result of the specific genetic disposition of the individual hence the plethora of treatments.
The semiotics of breast cancer
There was however some generalized advice for the patients, for example in regard to hygienic and cosmetic products: P they [doctors] advise you to use baby shampoo because it is soft and wild, of course, it's fresh hair that's just like baby hair coming back again. And it's things like that you don't realize and it's actually really painful when you are having chemotherapy and your hair falls out, There is also the issue of how a person changes their attitudes to health when they are diagnosed with breast cancer. 8 Breast cancer side-effects and sales -matching symptoms to products
It is obvious from the data that effects of breast cancer continue long after a patient has been given a 5-year clearance. An example of a common complaint associated with the condition is Lymphedema. This is also a condition that the organization makes products for:
P … but the rosemary ointment is really good for joint pain and Stephany had really bad tennis elbow … because she's got lymphedema in 1 arm, she counteracts everything with the other arm, and through that she is getting a problem with her elbow and they said, 'Try this,' and she put it on and it really helped her.
Lymphedema is a condition commonly associated with breast cancer as it occurs when lymph nodes (under the arms) are removed to assess if the cancer has spread (American Cancer Society 2014). The excessive displacement of fluid in the nodes can lead to secondary disorders (Rockson 2001) and so is a serious side-effect of the breast cancer treatment. One of the interviewees related that she only can drive automatic cars due to the restraints on her arms use. Hence the unlikely connection between breast cancer -due to the lymph node removal, and car selection highlights how far reaching the side-effects of breast cancer can be. But also the possible commercial opportunities that come from it.
The organization also has multiple products that are targeted towards the dermatological effects of chemotherapy and radiography such as, Calendula ointment for eczema, Jojoba oil for conditions such as erythrodysesthesia which causes inflamed and reddened skin usually on the hands, feet or sometimes elbow. The same product is also used for radiography burns and bruising; other organic products such as soaps are suitable for those with alopecia (hair loss; Hackbarth et al. 2008) . The way the products are marketed encapsulates what the organization wishes them to represent. Take for example the text associated with Calendula ointment:
Calendula has been used for centuries as a medicinal herb and is renowned for its antiinflammatory properties. Massage pure and natural Calendula Ointment onto dry and irritated skin and let the marigold flower work to reduce itchiness including insect bites. Olive Oil moisturizes and Rose helps to repair weakened and damaged skin. There are many uses for the Calendula Ointment but we often receive feedback from customers who tell us how effective the balm is on eczema and also to reduce redness caused by sun exposure.
In the future the organization is also going to formulate a shampoo suitable for those undergoing hair regrowth. It needs to be stated that there is an issue due to the legal consequences of naming a product as a cure for Cancer. This is not how the products themselves are marketed but there is a hesitancy in directly associating the products with the condition itself:
D … the minute that you associate let's just say a product with say … and say it's for cancer, then you have got a whole different ball game with your products. You have to go down so many loops and … I don't think, in any product that's out on the market, you cannot claim that it has a reducing effect on cancer
We can see that even if patients are using treatments from the organization that help the cancer recovery process it can never be stated as such due to legal issues around proof in medical product labelling (Stern 2006) . In contrast to the organizations' complications with treatment, one of the therapists also highlighted where she thought that the existing clinical approach to breast cancer was ineffective.
D I think the NHS 5 fails because it doesn't treat the whole person, the diet, the exercise. It just does the medical side. Whereas I think here we can give a little bit more information.
So far the semiotics trajectory of breast cancer in terms of physical factors has been defined by the stage of the disease, the type of carcinomas and so tumor, the biological age of the patient and so the changes associated with a particular stage of life (puberty, menopause), and the medication a person is assigned. The final alteration that makes up the somatic semiotic puzzle is the progression of the treatment schemes in the research of breast cancer. One of the interviewees who was both a sufferer and also works with breast cancer patients remarked of her own experience: P Science is moving forward at such a pace, that what they said they couldn't do for me when I had it in 2007-2008 they are now doing it for people in 2014
Equally, there is now retrospective treatment available for patient like P who was not able to access the treatment they needed at the time they had the physical manifestation of the condition. This is reflected in that over a 10 year period (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) (1999) (2000) breast cancer death rates in the USA and the UK has been reduced by 25 % (Peto et al. 2000) .
Discussion
The sign and the symptom
Just as the author sought the genesis of a semiotic description of breast cancer from Hippocrates, the same is required to make a distinction between symptom and sign. Heidel (1941) discusses the role of symptoms from a Hippocratic stand point, drawing mainly from Prognostics and Epidemics 1, he described symptoms as general in nature, a transferable characteristic observable in patients regardless of location, gender, race etc. it is this standpoint that led Sebeok (2001a: 51) to observe "Hippocrates studied disease as a naturalist." This however is not true of Galen who it is suggested was more empirical in his approach (Phillips 1973; Sebeok 2001a ). This can clearly be seen by the sheer volume of ailments listed by Galen (1.4), but his characterization of symptoms or epiphenomenon as is it termed does seem divergent from one treatise (De symptomatum differentiis) to another (De methodo medendi) where he classifies symptoms into four terms. The unifying theme between Galen's works however is that symptoms are manifestations of something 'contrary to nature' (ibid).
In a more modern context Sebeok (1986); Sebeok (2001b: 47-50 ) provides a synthesis of literature in connection to the debate around the demarcation between a sign a symptom. Here he points to Shands (1970b: 52) as who suggested that a medical symptom is something felt rather than something displayed which is closer to a sign. Sebeok also suggests that the same point is postulated by Von Uexküll (1982) that the endo/exo dichotomy is the distinguishing feature between a symptom and a sign hence Sebeok (2001b: 47) stated "The shift from physiological process [symptom] to semiosis [sign] is a consequence of the fact that the observer assumes a hypothetical stance within the observed system." If we wish to ground this issue in a Peircian system, (which is done with a touch of irony given that Peirce, according to his own Physician G. Alto Pobe had an in-depth knowledge of medicine (Sebeok 1981: 37) , but that this knowledge was rarely put to use in Peirce's own works (Sebeok 2001b: 48) we may turn to Staiano (1982: 331) who observed that "the appearance of a symptom in an individual is thus an indexical sinsign, while the symptom interpreted apart from its manifestation becomes an indexical legisign." This progression from the secondness of the sinsign to the thirdness of the legisign and their relative indexical natures will become more important when the issue is connected to commodification. The quote does highlight how externalization becomes a mediating term when delaminating between signs and symptoms. Throughout this paper best practice would be a clear distinction in the application of the terms symptom and sign, however as the medical and semiotic designations are not entire distinct there will inevitably be deficiencies on my part.
Medicine of the mind and the body
In I think I am Verb Sebeok (1986: 46) states: "Symptom always appears in conjunction with sign, but the precise nature of the vinculum is far from obvious." Hence when attempting to address and integrate opposing issues in medical theory one may feel like Oedipus standing in front of the Sphinx (Baer 1988) as the riddle of the Sphinx involves the interrelation of incompatible realms (1988: 101). The division of medical symptoms into material and non-material analytical sections can be allocated to the effect of Descartes' dualism on medical science. It is no secret that Descartes thought of the human person as being composed of res cogitans and res extensa. Consequently he also applied this ideas to symptomology (Lindeboom 1978: 55) . Interestingly Deely (2003) suggest that res cogitans should be superseded by the term semiotic animal (animal semeioticum), adapted from Aquinas' animal rationale to express the shift from realism to idealism that has occurred. Similarly in the preface of the book of the same name Deely et al. related: "the formula "semiotic animal" effectively displaces for contemporary understanding the modern formula "res cogitans" for developing awareness both of what is unique about the human being (capacity to reflect with signs on signs in discriminating objects and things) and also of our place in nature and alongside the other lifeforms" (2005: foreword).
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These two substances Baer (1988: 68) appropriately labelled "a thinking substance (res cogitans) without extension and an extended substance (res extensa) without thinking." The impression upon clinical practice of these ideas is reinforced by Frank: Western Medicine is rooted in the materialistic tradition, reinforced by Descartes' formulation of a mind-body dichotomy … the patient's body is the area in which the physician and the pathogen battle for supremacy. The patient himself is a passive bystander whose main task is to follow the doctor's orders. To be sure, he may influence the course of the disease, but only indirectly, for example, by failing to take his medicine or going off his diet; but he cannot consciously enhance the healing process. (Frank 1975: 127) This dualistic approach represents a complete departure from the Hippocratic medical traditions, for example we find the following passage in Plato's Charmides: "But our king Zalmoxis, he said who is a god, says that just as one should not attempt to cure the eyes apart from the head, nor the head apart from the body [soma], so one should not attempt to cure the body apart from the soul [psyche]" (Plato 1992: 62) .
The terms soma and psyche have been included in parenthesis here to highlight that since Descartes' dualistic influence is it only in the last 80 years that a return to psychosomatic medicine has occurred (Kiecolt-Glaser et al. 2002) . Even now the prevalence of psychosomatic medicine is low in the medical profession. The notable exception being in Germany, thanks almost solely to the pioneering and vast corpus of work left by Thure von Ueküll (Tuffs 2004) . In most clinical settings the immunological sign has been cut in two, between the psyche and the somatic. The idea of an interpretant producing further signs is only addressed in either a somatic or a psychological sense, the two are seldom combined. For example if recall the quote P … this drug that I'm on now, that has different side effects. So the last lot of drugs I was on, I was taking 3 tablets a day, but the only one that was helping to prevent the cancer coming back was one of them called Tamoxifen. The other 2 I had to take were to counteract side effects I was getting from the Tamoxifen.
The somatic symptoms (return of cancer) are treated with further somatic treatment (Tamoxifen) which produces side-effects (symptoms themselves) that are again treated somatically (2 other tablets). This raises an obvious issue as both patients and clinicians recognise through a posteriori knowledge that a condition incorporates both somatic and psychological constituents, so how does one square the circle in addressing the interaction between the both?
The initial task in explaining breast cancer symptomatology from a semiotic perspective is to address the personification of the condition. We talk of disease by the interpretation of symptoms as if they were entities in themselves, by personifying symptoms as things, in the way one has a headache or a cold. As Baer relates: "all these schmatizations [the personifications] are sensory-linguistic fictions which transform a non-differentiated and flowing world (already and interpretation) into a relatively stable, calculable and controllable world " (1988: 81) .
The term fiction is used by Baer (1988) 6 firstly in reference to Cartesian somatic ideas, as in the sense that one cannot have an illness such as a cold as it is not a singular condition. But a constantly evolving, and mutating set of viruses, whose exact symptoms and manifestations are historically and genetically contingent. Secondly from a Peircian point of view both the somatic and the psychological interpretants form part of an unlimited semiosis. Hence one may ask exactly what there is to have? As Peirce (EP 2: 8) stated "Icons and indices assert nothing." I do not feel however in this context that we must adhere to Wittgensteinʼs (1921: 108) maxim: "whereof one cannot speak, one must be silent." It is clear that a symptom is not a thing in itself but as Baer (1988: 86) states: "the symptom, because of this permanent alterity, cannot come to itself." The symptom is but a manifestation of a transient process, within a larger labyrinthine structure that we term a disease.
From symptoms to sales
It is accepted that as Baer (1988: 86) expresses "semiosis is infinite … symptomatology is infinite" but it also has to be stated that the fictional helps a patient negate the Peirce's concept of unlimited semiosis to produce a relatively stable, calculable and controllable world (1988: 86) even if we realize that such a thing is misrecognized. This need to fictionalize speech in regard to a situation while accepting that the word or speech is false is a phenomena Derrida (1967) termed sous rature, rendered as under erasure in the English translation by Derrida and Spivak (1998) . The usage of such a term first being associated with Heidegger and being related more to the specific act of written erasure such as "des Seins als sein herstammt," which we find in the forward of the aforementioned publication (1956: 5) .
This process of constructing fictions on the back of a disease is exactly the mechanism that allows a symptom to become commoditized. This process is rooted in the erasure overcoming the purely somatic conception of a symptom. Take for example the somatic consequences of breast cancer which include: hormonal therapy, mastectomies, hair loss, inflammation, itching and lesions of the dermis (the surface of the skin) among others (Williams et al. 1999) . Cognitive therapy and counselling is offered to patients with the symptoms as a supplementary service but the priority for the clinician and the medical staff as encapsulated by Frank (1975) is to treat the somatic symptom with a somatic treatment such as Tamoxifen. Contrast this then with the experience (psychological symptoms) of the breast cancer patients documented:
F psychological it [breast cancer] never ever goes away … it's always there, even when you get your 5-year clearance … it's always in the back of your mind, if you get a lump or if you're coughing or if you've got headaches you're still stuck thinking 'oh my God is it coming back?'
The somatic treatment does nothing to ease the loss of self-identity that comes with mastectomies or hair loss. Due to the gendered nature of the condition (Fentiman et al. 2006 ) the somatic treatment does little to address the loss of femininity either (Berterö and Chamberlain Wilmoth 2007; Young 1990) . The verbalization of the psychological symptoms are the result of the erasure process, and they are also the signs that the organizations uses to attract its clients. Similar examples are found in the marketing of health campaigns. Anthropomorphic slogans like Cancer Research UK's Lets Beat Cancer or more the potent "stand up to cancer, it's payback time" which is a registered brand mark of Cancer Research UK (2014) . Perhaps the most clear and literal example of the anthropomorphism of breast cancer is given in Crompvoets (2012) who cites the marketing literature of Anita Care, a prosthesis manufacturer: "Many breast prostheses are not made with this principle [restoration of the feminine] in mind as they denigrate to purely technical products. For many they therefore remain nothing more than a foreign body" (Anita Care 2001).
Anita Care literally characterize other prosthesis manufacture's products of being a different body. Without doubt the use of the term foreign body given its medical context is deliberately inflammatory. The process of erasure through the anthropomorphism of sinsigns into legisigns, forms a small part I believe of what Charon (2008) calls narrative medicine, which is neatly described by Staiano-Ross (2012: 41) : "The narrative is, for the patient, often a means of self-portraiture and a method of placing oneself in a desired position, whereas the physician may use it to accomplish the reverse, offering a less desired social status." This con-struction of 'fiction' in the psychological sense directly parallels the de-construction of the symptom in the somatic biomedical process. e. g., the slow learning process by which the exact genetic features of breast cancer are being discovered. See Figure 3 for a geometric example of this. This well-warn classical dichotomy of endo/exo can be, of course, framed in a multitude of ways. The move from deconstruction to con-struction, from the somatic to the psyche represents, if we choose to invoke the ontic shift using Heidegger as Bourdieu (1988) has, for example, the shift from the ontic dermatology (existentiell) to the ontological (existentiale) semiotic oncology. Similarly one might invoke Hegel's distinction between das Abstrakte and das Konkrete. Or more simply the transition from a dualistic to a non-dualistic approach in medicine. The most relevant distinction in terms of medicine to the this issue would be concepts of Umwelt and Innenwelt (Von Uexküll 1909) as Sebeok (1986: 53) relates "It would not appear unreasonable to expect a finely attuned reciprocal confirmation between man's internal states and 'reality,' between his Innenwelt and the surrounding Umwelt, or more narrowly between symptoms and their interpretations." Here I feel it would be useful to return briefly to the data, if we recall from the previous section: The semiotics of breast cancer D I think the NHS fails because it doesn't treat the whole person, the diet, the exercise. It just does the medical side. Whereas I think here we [the organization] can give a little bit more information.
I would assert that when D talks about a little bit more information it is the construction process that she is referring to, a process that can only happen in a non-dualistic medical approach. The interviewees exhibited behaviors such as switching to organic foods and other lifestyle choices that could be catered for without the use of the products the organization sold. Hence the commodification of a condition in the organization analysed is by no means the only way in which it functions. There are other potential markets that exist e. g., automatic cars for people with Lymphedema for example, but it represents a deliberate attempt to adapt a product to the sign processes of a condition. But what I feel is critical to this work is not the addition of more case studies to the endo/exo dichotomy but the means by which sinsign and legisign are connected. I might tentatively postulate that the commodification of medical signs occurs at the point at which an indexical sinsign transitions into an indexical legisign, under erasure, is the process by which a symptom becomes saleable. This observation is itself not novel, one might for instance point to Cavalli's distinction between invention and innovation: The difference from invention to innovation, thus, is to be found in the acknowledgment that innovation is primarily a social fact (sales and marketing are clearly not technical aspects), whereas invention remains a technical fact (Cavalli 2007: 958) The transition from the factual nature or secondness of the sinsign to the law based system of the legisign is what makes this commodification possible. Here the rules being the socio-economic rules of markets, which Bourdieu (1984); Bourdieu (2000) along with others has demonstrated are necessarily part of the same system. In her paper on the semiotics of pink ribbons for breast cancer advertisements Wagner (2005) walks us through a similar process. The transition from the semiosis of the colour pink [qualisign] to the "ribbon's meaning evolving from a personal message of forgiveness [sinsign] to an internationally recognized metaphor for social awareness [legisign]" (Wagner 2005: 209) . My postulation around the connections of sinsign to legisign is not therefore novel except in its attempt to use Derrida's concept of erasure as an explanatory causal mechanism.
Conclusions
In Semiotics in the United States Sebeok (1991: 118) wrote that "semiotics' overriding mission is and will be to 'mediate between reality and illusion,' to penetrate to the illusion behind the reality… -to decompose it, demystify it, and, in back of that, unveil yet another reality, of an intenser texture still." I expect my attempt to adhere to this will naturally fall short. Equally I may be guilty of a mechanistic application of semiotic concepts to medicine (Mounin 1981) . If my excessive sibilance can be excused, I feel it is clear that medical semiotics as a framework functions as a system that can integrate the physical and mental signs and symptoms simultaneously. Whereas in most medical models one must adhere to the false dichotomy between psychiatry and biochemistry (Kawade 1996) . Semiotics offers a non-dualistic approach to the medical analysis of mind and body as a singular unit. It does not have to break the symptoms or the treatment process into artificial parts for the sake of reasoning. It can expose the internal contradictions that arise in medical processes. For example the unexpected consequence of pushing for a nondualistic approach in symptomology has opened up a pathway for symptoms to become commoditized. This seems ironic because non-dualism in medicine was meant to push the subject in a more humanistic, natural, spiritual direction away from cold Cartesian rationalism (Schwartz and Wiggins 2010) . This has in part helped to create an equally debased situation where symptoms can through the same logic be turned into saleable items -hence the titular assignation of sign, symptoms and sales in the this paper. This is not to deny the effectiveness of the treatments on offer from either a somatic or a psychological point of view or both. For as Kull (1998) remarked 'semiotics is more a standpoint that a set of methods or ideology', but to highlight the issue itself and also illustrate the power of medical semiotics as an analytical tool.
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